Results

eNauka >  Rezultati >  Efficacy and safety of long-acting pasireotide or everolimus alone or in combination in patients with advanced carcinoids of the lung and thymus (LUNA): an open-label, multicentre, randomised, phase 2 trial
Naziv: Efficacy and safety of long-acting pasireotide or everolimus alone or in combination in patients with advanced carcinoids of the lung and thymus (LUNA): an open-label, multicentre, randomised, phase 2 trial
Autori Ferolla, Piero; ...; Stankovic, Miona; ...; (broj, koautora 22)
Godina: 2017
Publikacija: LANCET ONCOLOGY
ISSN: 1470-2045 Lancet Oncology Pretraži identifikator
Tip rezultata: Naučni članak
Kolacija: vol. 18 br. 12 str. 1652-1664
DOI: 10.1016/S1470-2045(17)30681-2
WoS-ID: 000417001900043
Scopus-ID: 2-s2.0-85032198954
URI: https://enauka.gov.rs/handle/123456789/818569
Projekat: Novartis Pharma AG
Izvor metapodataka: (Preuzeto iz Nasi u WoS)
M-kategorija: 
21a+M21a+ - Vodeći međunarodni časopis kategorije M21a+

129
SCOPUSTM
77
OpenCitations
111
WEB OF SCIENCETM
Altmetric
Dimensions
Unpaywall

Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.